Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brittany Dyr
Institution:
LabCorp (United States)
Observed institutions:
LabCorp (United States),
Sequenom (United States)
ORCID:
0000-0002-6304-4276
Observed ORCID:
0000-0002-6304-4276
OpenAlex ID:
A5034806678
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
2021
·
Erica Soster
, Theresa Boomer
, et al.
·
Genetics in Medicine
·
43
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
2019
·
Brittany Dyr
, Theresa Boomer
, et al.
·
PLoS ONE
·
27
PDF
Obesity and no call results: optimal timing of cell-free DNA testing and redraw
2021
·
Maeve K. Hopkins
, Nathanael Koelper
, et al.
·
American Journal of Obstetrics and Gynecology
·
25
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
2023
·
Erica Soster
, Brittany Dyr
, et al.
·
Frontiers in Genetics
·
14
PDF
Obesity and no-call results: optimal timing of cell-free DNA testing and redraw
2021
·
Maeve K. Hopkins
, Nathanael Koelper
, et al.
·
American Journal of Obstetrics and Gynecology
·
10
Not all low fetal fraction cell‐free DNA screening failures are at increased risk for aneuploidy
2021
·
Samantha Caldwell
, Eyad Almasri
, et al.
·
Prenatal Diagnosis
·
10
Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory’s Retrospective Experience
2023
·
Erica Soster
, Brittany Dyr
, et al.
·
Genes
·
4
PDF
Spinal Muscular Atrophy: Ordering Trends Pre- and Post-ACOG Committee Opinion 691 [17O]
2019
·
Brittany Dyr
, Kimberly Fanelli
, et al.
·
Obstetrics and Gynecology
·
3
Cytogenetic and Microarray Analysis Follow‐Up of PGT‐A Mosaic and Sex Discrepant Embryos During Pregnancy: Absence of Confirmation and Follow‐Up Recommendations
2026
·
Laura A. Kline
, Vanessa A. Nitibhon
, et al.
·
Prenatal Diagnosis
·
1
Correction to: Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy number variants
2021
·
Erica Soster
, Theresa Boomer
, et al.
·
Genetics in Medicine
·
1
Clinical Laboratory Experience With Prenatal cfDNA Screening in Triplet Pregnancies
2025
·
Erica Soster
, Brittany Dyr
, et al.
·
Prenatal Diagnosis
PDF
727 One laboratory’s experience with prenatal cfDNA screening and incidental findings concerning for maternal neoplasia
2024
·
Brittany Dyr
, Erica Soster
, et al.
·
American Journal of Obstetrics and Gynecology
PDF
906 Patient Weight, Not Height, Significantly Influences cfDNA Screening Performance
2024
·
Vanessa Nitibhon
, Brittany Dyr
, et al.
·
American Journal of Obstetrics and Gynecology
PDF
The disappearing act: diminishing Y chromosome cfDNA contribution in vanished twin pregnancies
2023
·
Samantha Caldwell
, Brittany Dyr
, et al.
·
American Journal of Obstetrics and Gynecology
PDF
MATERNAL FIBROID IMPACT ON CELL FREE DNA (cfDNA) SCREENING
2022
·
Samantha Caldwell
, Brittany Dyr
, et al.
·
Fertility and Sterility
Fertility Centers and Cell-free Fetal Dna Screening (cffdna): a Review of Maternit® 21 Plus Performance in the Reproductive Health Setting
2021
·
Vanessa Nitibhon
, Brittany Dyr
, et al.
·
Fertility and Sterility
The Discovery of Unbalanced Translocations through Genome-Wide cfDNA Testing [32R]
2018
·
Brittany Dyr
, Theresa Boomer
, et al.
·
Obstetrics and Gynecology
Impact of Co-Twin Demise on Circulating Cell-Free DNA (ccfDNA) Testing [10R]
2016
·
Brittany Dyr
, Theresa Boomer
, et al.
·
Obstetrics and Gynecology
Show more works
View as search
Works count:
18
Citation count:
138
H-index:
6
I10-index:
6
Year
Topic
Type